NCT00883103

Brief Summary

The purpose of this study is to compare the pain perception between lidocaine and plain aqueous gel during assessment of postvoid residual volume and the Q-tip test.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
137

participants targeted

Target at P75+ for phase_4 pain

Timeline
Completed

Started Nov 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2007

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2008

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 15, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 17, 2009

Completed
2.4 years until next milestone

Results Posted

Study results publicly available

September 13, 2011

Completed
Last Updated

September 13, 2011

Status Verified

August 1, 2011

Enrollment Period

10 months

First QC Date

April 15, 2009

Results QC Date

July 18, 2011

Last Update Submit

August 10, 2011

Conditions

Keywords

female urethral catheterizationLidocainelubricantQ-tip testQ tip testK-Y jellypain perceptionstraight catheterization

Outcome Measures

Primary Outcomes (1)

  • Patient's Perception of Pain Using the Wong-Baker FACES Visual Scale: 0 - no Pain; 5 - Worst Imaginable Pain

    A sterile catheter lubricated with the allocated gel was placed transurethrally into the bladder to measure the postvoid residual volume. After removal of the catheter, a cotton swab, coated with the same allocated gel, was advanced to the urethrovesical junction until resistance was felt. The angle of the swab with the horizontal plane was measured at rest and with a Valsalva maneuver. Immediately following the Q-tip test, the patient's perception of pain level was measured by Wong-Baker FACES Pain Scale, a visual scale where 0 represents no pain and 5 represents worst imaginable pain.

    Immediately after the examination

Study Arms (2)

Lidocaine

ACTIVE COMPARATOR

2% Lidocaine jelly will be applied onto the catheter and then the cotton swab during evaluation of postvoid residual and the Q-tip test.

Drug: 2% Lidocaine jelly

Aqueous gel

PLACEBO COMPARATOR

Plain aqueous gel as placebo will be applied onto the catheter and then the cotton swab during evaluation of postvoid residual and the Q-tip test.

Drug: Plain aqueous gel

Interventions

2% Lidocaine jelly will be applied onto the catheter and then the cotton swab during evaluation of postvoid residual and the Q-tip test.

Lidocaine

Plain aqueous gel will be applied onto the catheter and then the cotton swab during evaluation of postvoid residual and the Q-tip test.

Also known as: Surgilube
Aqueous gel

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All women who presented to a single urogynecologist's office for an initial consultation with a complaint of urinary incontinence and/or pelvic organ prolapse

You may not qualify if:

  • Being a minor
  • Pregnancy
  • Allergy to Lidocaine or aqueous lubricant gel
  • Any current use of analgesia
  • Structural abnormalities of the urethra
  • Active genital Herpes or other vulvovaginal infections or inability to cooperate with pain assessment due to mental disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baystate Medical Center

Springfield, Massachusetts, 01199, United States

Location

Related Publications (1)

  • Harmanli OH, Okafor O, Ayaz R, Knee A. Lidocaine jelly and plain aqueous gel for urethral straight catheterization and the Q-tip test: a randomized controlled trial. Obstet Gynecol. 2009 Sep;114(3):547-550. doi: 10.1097/AOG.0b013e3181b43808.

MeSH Terms

Conditions

Pain

Interventions

phenylmercury borate

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Oz Harmanli, MD
Organization
Baystate Medical Center

Study Officials

  • Oz Harmanli, MD

    Baystate Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 15, 2009

First Posted

April 17, 2009

Study Start

November 1, 2007

Primary Completion

September 1, 2008

Study Completion

September 1, 2008

Last Updated

September 13, 2011

Results First Posted

September 13, 2011

Record last verified: 2011-08

Locations